New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 73, Issue 4, Pages 504-517
Publisher
Wiley
Online
2011-10-28
DOI
10.1111/j.1365-2125.2011.04134.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease
- (2017) Antonino Cattaneo et al. JOURNAL OF ALZHEIMERS DISEASE
- Cell Signaling Pathways and Iron Chelation in the Neurorestorative Activity of Green Tea Polyphenols: Special Reference to Epigallocatechin Gallate (EGCG)
- (2017) Silvia A. Mandel et al. JOURNAL OF ALZHEIMERS DISEASE
- The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
- (2017) Hozefa Amijee et al. JOURNAL OF ALZHEIMERS DISEASE
- RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?
- (2017) Shi Du Yan et al. JOURNAL OF ALZHEIMERS DISEASE
- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- Dimebon (Latrepirdine) Enhances Mitochondrial Function and Protects Neuronal Cells from Death
- (2017) Shouting Zhang et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers in Alzheimer's disease drug development
- (2011) Jeffrey L. Cummings Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us
- (2011) Nina F. Schor ANNALS OF NEUROLOGY
- Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- (2011) Orestes V. Forlenza et al. BRITISH JOURNAL OF PSYCHIATRY
- Possible Involvement of Programmed Cell Death Pathways in the Neuroprotective Action of Polyphenols
- (2011) S. Bastianetto et al. Current Alzheimer Research
- Anti-β-Amyloid Immunotherapy for Alzheimers Disease: Focus on Bapineuzumab
- (2011) Francesco Panza et al. Current Alzheimer Research
- γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
- (2011) Bruno P. Imbimbo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Preclinical studies of human disease: Time to take methodological quality seriously
- (2011) H. Bart van der Worp et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing
- (2011) Stefan F. Lichtenthaler et al. JOURNAL OF NEUROCHEMISTRY
- Unknown
- (2011) Daniel Paris et al. MOLECULAR MEDICINE
- Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation
- (2011) J. M. Ringman et al. NEUROLOGY
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Dementia screening, biomarkers and protein misfolding
- (2011) James E. Galvin Prion
- Prevention trials in Alzheimer's disease: An EU-US task force report
- (2011) Bruno Vellas et al. PROGRESS IN NEUROBIOLOGY
- A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease
- (2010) Adrian W. Laxton et al. ANNALS OF NEUROLOGY
- Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory
- (2010) Daniela Puzzo et al. ANNALS OF NEUROLOGY
- Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
- (2010) Eric M Reiman et al. Biomarkers in Medicine
- Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
- (2010) Kawser Akter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2010) Michael Gold et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease
- (2010) Richard Dodel et al. DRUGS
- Bapineuzumab
- (2010) Geoffrey A Kerchner et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- β-Secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice
- (2010) Wan-Pin Chang et al. FASEB JOURNAL
- Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study
- (2010) S. P. Kennelly et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Immunotherapy for Alzheimer’s disease
- (2010) D. Morgan JOURNAL OF INTERNAL MEDICINE
- Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
- (2010) Johanna Magga et al. Journal of Neuroinflammation
- Psychopharmacological Neuroprotection in Neurodegenerative Disease: Assessing the Preclinical Data
- (2010) E. C. Lauterbach et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- The use of mass spectrometry to study amyloid-β peptides
- (2010) Giuseppe Grasso MASS SPECTROMETRY REVIEWS
- Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?
- (2010) Bo Su et al. MOLECULAR NEUROBIOLOGY
- Alzheimer's failure raises questions about disease-modifying strategies
- (2010) Andy Extance NATURE REVIEWS DRUG DISCOVERY
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- PPARγ transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons
- (2009) Jing Du et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Methylene blue and Alzheimer's disease
- (2009) Murat Oz et al. BIOCHEMICAL PHARMACOLOGY
- CHF5074, a novel γ-secretase modulator, attenuates brain β-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease
- (2009) BP Imbimbo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alternative Aβ Immunotherapy Approaches for Alzheimers Disease
- (2009) Terrence Town CNS & Neurological Disorders-Drug Targets
- Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
- (2009) Mary Lambert et al. CNS & Neurological Disorders-Drug Targets
- Antibody Responses, Amyloid-β Peptide Remnants and Clinical Effects of AN-1792 Immunization in Patients with AD in an Interrupted Trial
- (2009) Tyler Kokjohn et al. CNS & Neurological Disorders-Drug Targets
- TGF-β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease
- (2009) Filippo Caraci et al. CNS Neuroscience & Therapeutics
- A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
- (2009) Sergey Kalinin et al. Current Alzheimer Research
- Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
- (2009) David B Henley et al. EXPERT OPINION ON PHARMACOTHERAPY
- Secretase inhibitors and modulators for Alzheimer’s disease treatment
- (2009) Taisuke Tomita Expert Review of Neurotherapeutics
- RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer’s disease animal model
- (2009) H. J. Cho et al. FASEB JOURNAL
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inherent Anti-amyloidogenic Activity of Human Immunoglobulin γ Heavy Chains
- (2009) Sharad P. Adekar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
- (2009) Pierre N. Tariot et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- (2009) John Hardy JOURNAL OF NEUROCHEMISTRY
- -Amyloid Monomers Are Neuroprotective
- (2009) M. L. Giuffrida et al. JOURNAL OF NEUROSCIENCE
- How can we recognize “disease modification” effects?
- (2009) E. R. Siemers Journal of Nutrition Health & Aging
- Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
- (2009) C. Wischik et al. Journal of Nutrition Health & Aging
- Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
- (2009) S. Gauthier et al. Journal of Nutrition Health & Aging
- Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer’s disease: ADAS-cog subscale results from the Alphase study
- (2009) D. Saumier et al. Journal of Nutrition Health & Aging
- Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein -Secretase for the Treatment of Alzheimer's Disease
- (2009) R. L. Martone et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
- (2009) L. Serenó et al. NEUROBIOLOGY OF DISEASE
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation
- (2009) Hung-Ming Wu et al. NEUROPSYCHOPHARMACOLOGY
- Amyloid Activates GSK-3β to Aggravate Neuronal Tauopathy in Bigenic Mice
- (2008) Dick Terwel et al. AMERICAN JOURNAL OF PATHOLOGY
- Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
- (2008) Henrik Zetterberg et al. ARCHIVES OF NEUROLOGY
- Structure-Function Implications in Alzheimers Disease: Effect of Aβ Oligomers at Central Synapses
- (2008) Waldo Cerpa et al. Current Alzheimer Research
- Memapsin 2 (Beta-Secretase) Inhibitors: Drug Development
- (2008) Arun Ghosh et al. Current Alzheimer Research
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- Therapeutic Potential of γ -Secretase Inhibitors and Modulators
- (2008) Bruno Imbimbo CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons
- (2008) Kathie M. Bishop et al. EXPERIMENTAL NEUROLOGY
- Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery
- (2008) Alan H. Nagahara et al. EXPERIMENTAL NEUROLOGY
- Raft aggregation with specific receptor recruitment is required for microglial phagocytosis of Aβ42
- (2008) Dixie-Ann Persaud-Sawin et al. GLIA
- A feasibility and tolerability study of lithium in Alzheimer's disease
- (2008) Alastair Macdonald et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
- (2008) Rachelle S Doody et al. LANCET
- Lithium may be useful in the prevention of Alzheimer’s disease in individuals at risk of presenile familial Alzheimer’s disease
- (2008) Heng-Liang Yeh et al. MEDICAL HYPOTHESES
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ
- (2008) Paul A. Adlard et al. NEURON
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
- Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers
- (2008) R. Robert et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
- (2008) P. Hemachandra Reddy et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More